Heterocyclic Compound for TADF OLED Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current organic light-emitting devices face limitations in achieving high efficiency and color purity due to the large difference between singlet and triplet energy levels in existing thermally activated delayed fluorescence (TADF) compounds, which affects their ability to utilize triplet excitons for light emission.
Innovation Solution
A heterocyclic compound with a specific molecular structure, including an indoloindole group and a triazine group linked via a phenylene or benzophenone group, is used in the emission layer to reduce the energy level difference and enhance the overlap between highest occupied molecular orbital and lowest unoccupied molecular orbital, promoting efficient delayed fluorescence.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of energy
If existing TADF compounds are used in the emission layer, then the device can achieve delayed fluorescence emission, but the large difference between singlet and triplet energy levels results in poor utilization of triplet excitons and low fluorescent efficiency
Solution Approach 1:
The patent modifies the molecular structure of TADF compounds by introducing specific heterocyclic groups (indoloindole, triazine) and linkers (phenylene, benzophenone) to change the energy level parameters. This structural modification reduces the energy gap between singlet and triplet states, enabling more effective triplet exciton utilization and improving fluorescent efficiency without losing the delayed fluorescence mechanism.
Solution Approach 2:
The patent employs composite molecular structures combining multiple functional groups (indoloindole donor group, triazine acceptor group, phenylene or benzophenone linkers) to create a TADF compound with optimized electronic properties. This composite approach allows simultaneous achievement of small singlet-triplet energy gap for triplet exciton utilization and high fluorescent efficiency.
2Productivity
If the energy level difference between singlet and triplet states is reduced to improve triplet exciton utilization, then fluorescent efficiency improves, but color purity may be affected
Solution Approach 1:
The patent applies local quality by assigning specific functional roles to different parts of the molecular structure: the indoloindole group provides electron donation and influences emission color, the triazine group provides electron acceptance and affects energy levels, and the phenylene/benzophenone linkers control the electronic coupling. This localized functional assignment allows independent optimization of color purity and fluorescent efficiency.
Solution Approach 2:
The patent carefully adjusts molecular parameters including the type of linker (phenylene vs. benzophenone), substitution patterns, and auxiliary groups to fine-tune both the energy gap for efficient triplet utilization and the HOMO-LUMO gap for desired emission color. This parameter optimization resolves the contradiction between fluorescent efficiency and color purity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The heterocyclic compound achieves high fluorescent efficiency and color purity by minimizing the energy level difference, allowing for the effective use of triplet excitons and improving the overall performance of organic light-emitting devices.
Implementation Method 1
the large difference between singlet and triplet energy levels in existing thermally activated delayed fluorescence (TADF) compounds, which affects their ability to utilize triplet excitons for light emission
Implementation Method 2
enhance the overlap between highest occupied molecular orbital and lowest unoccupied molecular orbital, promoting efficient delayed fluorescence
Data Source
AI summary
A heterocyclic compound and an organic light-emitting device including the heterocyclic compound, the heterocyclic compound being represented by Formula 1:


